Search results for: Oncology
Filter search results
Newly Published Analysis: Dementia: the R&D Landscape
16 November 2015
…elsewhere*. Key observations from the literature include: R&D costs are higher for neurology and Alzheimer’s disease (AD) (as well as respiratory and oncology) than other therapy areas Higher costs are…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…decision making. For OHE’s primer on MCDA, click here. 3. The Expanding Value Footprint of Oncology Treatments. Juan Carlos Rejon-Parrilla (OHE), Karla Herandez-Villafuerte (OHE), Koonal K Shah (OHE), Jorge Mestre-Ferrandiz…
Around The World in HTAs: Italy – What’s Next?
20 April 2023
…on Pricing of Medicines Reimbursed by the Italian National Health Service. Pharmacoeconomics. 2023 Jan;41(1):107-117. Russo, P., Marcellusi, A., Zanuzzi, M., et al. Drug Prices and Value of Oncology Drugs in…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…be agreed upon, building on learnings from the oncology space. Finally, Oriol addressed the “elephant in the room”: affordability from the payer perspective. He proposed moving away from the Fee…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…addition, case study analyses revealed significant possible savings, such as the €7.1 billion that could be saved during the period 2016-2020, through increased generic and biosimilar competition in the oncology…
Priscila Radu
20 September 2021
Priscila has published research on various health economics topics, including changes in HTA methods in several regions, assessment pathways for precision oncology, and regulatory landscape of digital health in the…
Chris Skedgel
15 July 2019
…He has been a Lead Economic Reviewer for the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Common Drug Review (CDR) and has led the development of NICE submissions in…
Patricia Cubi-Molla
4 September 2015
…HTA methods and contributed to studies on decision-making for innovative health technologies, oncology, primary care, climate action, and wider public spending. She has authored more than 25 peer-reviewed publications in…
Chittawan Poonsiri
4 September 2024
…University, Thailand. After graduation, she served as a hospital pharmacist, specializing in oncology patient care. Currently, she is a Senior Associate at the Health Intervention and Technology Assessment Program (HITAP)….